132 related articles for article (PubMed ID: 38153980)
1. Multiple sclerosis-associated uveitis - A series from South India.
Babu K; Janardhana GC; Murthy KR
Indian J Ophthalmol; 2024 May; 72(5):681-686. PubMed ID: 38153980
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum and management options in Vogt-Koyanagi-Harada disease.
Lodhi SA; Reddy JL; Peram V
Clin Ophthalmol; 2017; 11():1399-1406. PubMed ID: 28848322
[TBL] [Abstract][Full Text] [Related]
3. Association of Fuchs Heterochromic Iridocyclitis with Multiple Sclerosis.
Brichová M; Lízrová JP; Heissigerová J; Jeníčková D; Klímová A; Svozílková P
Cesk Slov Oftalmol; 2024; 80(Ahead of print):1001-1005. PubMed ID: 38538292
[TBL] [Abstract][Full Text] [Related]
4. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
5. Incomplete Vogt-Koyanagi-Harada in a 14-year-Old African American female with bilateral disc edema.
Ataei Y; Samara WA; Felton WL; Brar VS
Am J Ophthalmol Case Rep; 2021 Jun; 22():101114. PubMed ID: 34013096
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile and management with immunosuppressants and biologics in Behcet's uveitis: A cohort of 25 patients from a tertiary eye care center in South India.
Ramdoss J; Singh P; Ahmed AS; Biswas J
Indian J Ophthalmol; 2023 May; 71(5):1972-1976. PubMed ID: 37203067
[TBL] [Abstract][Full Text] [Related]
7. Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.
AlBloushi AF; Herbort CP; Abu El-Asrar AM
Int Ophthalmol; 2021 Dec; 41(12):4187-4195. PubMed ID: 34346004
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Alromaih AZ; Almater AI; Albloushi AF; Alkheraiji NF; Abu El-Asrar AM
Int Ophthalmol; 2023 Jan; 43(1):185-195. PubMed ID: 35945413
[TBL] [Abstract][Full Text] [Related]
9. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
Bouchenaki N; Morisod L; Herbort CP
Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
[TBL] [Abstract][Full Text] [Related]
10. Vogt-Koyanagi-Harada Disease: A Case Series in a Tertiary Eye Center.
Shrestha P; Sharma S; Kharel R
Case Rep Ophthalmol Med; 2021; 2021():8848659. PubMed ID: 33552608
[TBL] [Abstract][Full Text] [Related]
11. Proliferative retinopathy as a feature of Vogt Koyanagi Harada Disease: a report of two cases.
Magliyah MS; Al-Fakhri AS; Al-Dhibi HA
BMC Ophthalmol; 2020 Dec; 20(1):470. PubMed ID: 33261580
[TBL] [Abstract][Full Text] [Related]
12. A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy.
Minami K; Egawa M; Kajita K; Murao F; Mitamura Y
Case Rep Ophthalmol; 2021; 12(3):952-960. PubMed ID: 35082654
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
14. Review of Epidemiology of Uveitis in Asia: Pattern of Uveitis in a Tertiary Hospital in the Philippines.
Abaño JM; Galvante PR; Siopongco P; Dans K; Lopez J
Ocul Immunol Inflamm; 2017; 25(sup1):S75-S80. PubMed ID: 29083984
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease.
Abu El-Asrar AM; Dheyab A; Khatib D; Struyf S; Van Damme J; Opdenakker G
Ocul Immunol Inflamm; 2022 Apr; 30(3):750-757. PubMed ID: 32990482
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, clinical profile, investigations, and visual outcome of sarcoid intermediate uveitis in a tertiary eye care center in South India.
Ramdoss J; Jain A; Thejesvi GN; Biswas J
Indian J Ophthalmol; 2022 Jul; 70(7):2454-2457. PubMed ID: 35791132
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
18. Favorable clinical outcome with intravitreal aflibercept treatment in a case with bilateral choroidal neovascular membrane and quiescent Vogt-Koyanagi-Harada syndrome.
Ipek SC; Ayhan Z; Emre S; Saatci AO
GMS Ophthalmol Cases; 2020; 10():Doc23. PubMed ID: 32676268
[No Abstract] [Full Text] [Related]
19. Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature.
Rahman N; Artiaga JCM; Bouras K; Luis J; Rees A; Westcott M
J Ophthalmic Inflamm Infect; 2023 May; 13(1):27. PubMed ID: 37204477
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
Martin TD; Rathinam SR; Cunningham ET
Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
